Allied Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Buy
312
+1
+0.3% +$1.18K 0.03% 87
2026
Q2
$374K Sell
311
-1
-0.3% -$1.02K 0.05% 82
2026
Q1
$287K Hold
312
– – 0.04% 82
2025
Q4
$335K Sell
312
-14
-4% -$13.4K 0.05% 78
2025
Q3
$248K Buy
326
+59
+22% +$43.9K 0.04% 86
2025
Q2
$208K Sell
267
-3
-1% -$2.33K 0.04% 82
2025
Q1
$223K Hold
270
– – 0.04% 82
2024
Q4
$208K Buy
270
+18
+7% +$14.9K 0.04% 77
2024
Q3
$223K Sell
252
-17
-6% -$15.3K 0.04% 71
2024
Q2
$243K Hold
269
– – 0.06% 62
2024
Q1
$209K Buy
+269
New +$191K 0.05% 65

Other funds holding LLY

Allied Investment Advisors's LLY Position: Q3 2026 in Review

Allied Investment Advisors increased its Eli Lilly (LLY) stake by 0.32% in Q3 2026, buying an estimated $1.18K and bringing the position to 312 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #87.

Allied Investment Advisors first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $374K in Q2 2026. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Allied Investment Advisors held 312 shares of Eli Lilly worth $360K as of Q3 2026.
  • Allied Investment Advisors bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
  • Eli Lilly made up 0.03% of Allied Investment Advisors's portfolio in Q3 2026, its #87 holding.
  • Allied Investment Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • Allied Investment Advisors's Eli Lilly position peaked at $374K in Q2 2026.
  • 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Allied Investment Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.